Fennec Pharmaceuticals (FENC) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts FENC Hot Sheet
Join SI Premium – FREE
Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $15.11 million versus the consensus estimate of $14.65 million.
For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target
- Vertiv shares drop on acquisition skepticism, AI pullback
- Piper Sandler lists 5 chip stocks to buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
